Nve Corp /New/
NVEC Nasdaq Semiconductors & Related Devices Financials FY2017βFY2026
What Nve Corp /New/ does
No business description yet.
- Legal name
- NVE CORP /NEW/
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 10-K Β· May 6, 2026
- Accession Β· CIK
- 0001376474-26-000348
0000724910
Revenue and margins
Nve Corp /New/ had $26.3M of revenue in fiscal 2026, up 1.8% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 1.8% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $14.5M in fiscal 2026, 54.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Nve Corp /New/ returned $19.3M to shareholders in fiscal 2026, 134% of free cash flow. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Nve Corp /New/ can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $31.3M | $17.2M | $22.2M | $21.7M | $19.8M |
| Current ratio | 16.9x | 16.8x | 32.0x | 28.4x | 28.2x |
| Quick ratio | 14.8x | 13.3x | 25.1x | 22.0x | 22.0x |
| Total assets | $67.5M | $69.3M | $66.8M | $64.3M | $60.4M |
| Total liabilities | $2.9M | $2.2M | $1.2M | $2.0M | $2.1M |
| Shareholders' equity | $64.6M | $67.1M | $65.6M | $62.3M | $58.2M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 7 / 8 | 4 / 8 | 8 / 8 | 4 / 8 | 4 / 8 | 6 / 8 | 4 / 8 | 4 / 8 | 6 / 8 |
| Accruals ratio | 0.6% | β1.4% | β12.4% | β1.7% | β2.2% | 2.9% | 5.3% | β1.7% | 1.2% | β2.3% |
| Altman Z'' | 95.03 | 98.02 | 109.83 | 60.96 | 51.83 | 30.98 | 39.91 | 64.13 | 39.67 | 35.93 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $28.3M | $29.9M | $26.5M | $25.4M | $21.4M | $27.0M | $38.3M | $29.8M | $25.9M | $26.3M |
| Provision for credit losses | β | β | β | β | β | β | $0.0M | $0.0M | $0.0M | β |
| Gross profit | $22.2M | $23.6M | $21.3M | $20.5M | $17.2M | $20.7M | $30.2M | $23.0M | $21.6M | $20.7M |
| Research and development | $3.3M | $3.7M | $4.1M | $3.7M | $3.2M | $2.9M | $2.6M | $2.7M | $3.6M | $3.2M |
| Operating income | $17.4M | $18.5M | $15.9M | $15.5M | $12.7M | $16.3M | $25.6M | $18.5M | $16.0M | $15.9M |
| Pretax income | $19.1M | $20.0M | $17.7M | $17.3M | $14.2M | $17.5M | $27.1M | $20.5M | $18.0M | $17.8M |
| Income tax | $6.1M | $6.1M | $3.2M | $2.8M | $2.5M | $3.0M | $4.4M | $3.3M | $3.0M | $2.6M |
| Net income | $12.9M | $13.9M | $3.6M | $14.5M | $11.7M | $14.5M | $22.7M | $17.1M | $15.1M | $15.2M |
| Diluted EPS | $2.68 | $2.87 | $2.99 | $3.00 | $2.42 | $3.00 | $4.70 | $3.54 | $3.11 | $3.14 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | $12.4M | $15.2M | $14.2M | $15.9M | $13.4M | $12.5M | $19.1M | $18.2M | $14.3M | $16.7M |
| Capital expenditure | $0.5M | $0.6M | $0.1M | $0.1M | $0.1M | $0.5M | $0.9M | $0.0M | $1.3M | $2.2M |
| Free cash flow | $11.9M | $14.5M | $14.2M | $15.8M | $13.3M | $12.0M | $18.2M | $18.2M | $13.1M | $14.5M |
| Depreciation and amortization | $1.1M | $1.0M | $0.7M | $0.6M | $0.5M | $0.4M | $0.2M | $0.3M | $0.3M | $0.5M |
| Stock-based compensation | $0.0M | $0.0M | $0.1M | $0.0M | $0.0M | $0.1M | β | β | β | β |
| Share buybacks | β | β | β | $0.7M | $0.1M | $0.2M | $0.0M | $0.0M | β | β |
| Dividends paid | $19.3M | $19.4M | $19.4M | $19.4M | $19.3M | $19.3M | $19.3M | $19.3M | $19.3M | $19.3M |
| Dividends and buybacks | $19.3M | $19.4M | $19.4M | $20.1M | $19.4M | $19.5M | $19.3M | $19.3M | $19.3M | $19.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $27.8M | $25.5M | $19.4M | $27.2M | $18.1M | $31.3M | $17.2M | $22.2M | $21.7M | $19.8M |
| Current assets | $35.2M | $32.7M | $27.4M | $34.4M | $24.4M | $41.5M | $30.8M | $33.2M | $33.2M | $32.2M |
| Current liabilities | $1.1M | $1.0M | $0.8M | $0.8M | $1.0M | $2.5M | $1.8M | $1.0M | $1.2M | $1.1M |
| Inventory | $3.4M | $3.7M | $4.3M | $3.9M | $3.9M | $5.1M | $6.4M | $7.2M | $7.4M | $7.1M |
| Property and equipment, net | $1.4M | $1.3M | $0.9M | $0.6M | $0.3M | $0.6M | $1.3M | β | β | $3.7M |
| Total assets | $93.8M | $87.4M | $83.6M | $79.5M | $72.5M | $67.5M | $69.3M | $66.8M | $64.3M | $60.4M |
| Total liabilities | $1.1M | $1.0M | $0.8M | $1.5M | $1.6M | $2.9M | $2.2M | $1.2M | $2.0M | $2.1M |
| Shareholders' equity | $92.7M | $86.4M | $82.8M | $78.0M | $70.9M | $64.6M | $67.1M | $65.6M | $62.3M | $58.2M |
| Margins | ||||||||||
| Gross margin | 78.5% | 79.0% | 80.3% | 80.8% | 80.7% | 76.8% | 78.9% | 77.3% | 83.6% | 78.7% |
| Operating margin | 61.6% | 61.8% | 60.2% | 61.1% | 59.6% | 60.5% | 67.0% | 62.1% | 61.8% | 60.5% |
| EBITDA margin | 65.6% | 65.1% | 62.8% | 63.2% | 62.2% | 62.1% | 67.6% | 63.2% | 63.1% | 62.2% |
| Net margin | 45.7% | 46.6% | 13.6% | 57.2% | 54.7% | 53.8% | 59.3% | 57.5% | 58.2% | 57.7% |
| FCF margin | 41.9% | 48.7% | 53.5% | 62.3% | 62.3% | 44.5% | 47.5% | 61.2% | 50.4% | 54.9% |
| Returns | ||||||||||
| Return on capital employed | 18.8% | 21.3% | 19.2% | 19.7% | 17.8% | 25.1% | 38.0% | 28.2% | 25.3% | 26.9% |
| Return on equity | 14.0% | 15.5% | 4.3% | 18.1% | 15.7% | 21.4% | 34.5% | 25.8% | 23.6% | 25.2% |
| Return on assets | 13.8% | 15.4% | 4.2% | 17.8% | 15.4% | 20.7% | 33.2% | 25.2% | 23.0% | 24.4% |
| Return on tangible equity | 14.0% | 16.1% | 4.4% | 18.6% | 16.5% | 22.5% | 33.8% | 26.1% | 24.2% | 26.1% |
| Growth | ||||||||||
| Revenue growth | β | 5.4% | β11.4% | β4.0% | β15.9% | 26.3% | 41.7% | β22.1% | β13.2% | 1.8% |
| Net income growth | β | 7.4% | β74.1% | 302.7% | β19.5% | 24.1% | 56.4% | β24.5% | β12.0% | 0.9% |
| EPS growth | β | 7.1% | 4.2% | 0.3% | β19.3% | 24.0% | 56.7% | β24.7% | β12.1% | 1.0% |
| FCF growth | β | 22.7% | β2.7% | 12.0% | β16.0% | β9.6% | 51.1% | 0.4% | β28.4% | 10.8% |
| Share count change | β | 0.2% | 0.1% | β0.1% | β0.3% | 0.0% | β0.1% | 0.2% | β0.0% | 0.0% |
| Financial health | ||||||||||
| Current ratio | 32.1x | 33.0x | 32.8x | 43.2x | 23.7x | 16.9x | 16.8x | 32.0x | 28.4x | 28.2x |
| Quick ratio | 29.1x | 29.3x | 27.7x | 38.3x | 19.9x | 14.8x | 13.3x | 25.1x | 22.0x | 22.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.8% | 2.0% | 0.3% | 0.2% | 0.3% | 1.8% | 2.4% | 0.1% | 4.9% | 8.3% |
| Stock comp / revenue | 0.1% | 0.1% | 0.4% | 0.2% | 0.2% | 0.3% | β | β | β | β |
| Payouts / FCF | 163.1% | 133.1% | 136.9% | 126.7% | 146.1% | 162.2% | 106.5% | 106.0% | 148.2% | 133.7% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 4.0 | 8.0 | 4.0 | 4.0 | 6.0 | 4.0 | 4.0 | 6.0 |
| Altman Z'' | 95.0 | 98.0 | 109.8 | 61.0 | 51.8 | 31.0 | 39.9 | 64.1 | 39.7 | 35.9 |
| Accruals ratio | 0.6% | β1.4% | β12.4% | β1.7% | β2.2% | 2.9% | 5.3% | β1.7% | 1.2% | β2.3% |
Source: SEC EDGAR XBRL filings (CIK 0000724910). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.